Dr Reddys Laboratories Ltd

NSE :DRREDDY BSE :500124 Sector : Pharmaceuticals

Buy, Sell or Hold DRREDDY? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

20 Apr
5156.75
(3.80%)

19 Apr
4968.10
(1.53%)

16 Apr
4893.25
(0.98%)

15 Apr
4845.55
(1.43%)

13 Apr
4777.30
(-4.40%)

12 Apr
4996.95
(4.97%)

09 Apr
4760.30
(1.52%)

08 Apr
4689.05
(-0.08%)

07 Apr
4692.65
(1.59%)

06 Apr
4619.25
(1.37%)

05 Apr
4556.60
(-0.68%)

01 Apr
4587.65
(1.59%)

31 Mar
4516.00
(-0.05%)

30 Mar
4518.20
(2.55%)

26 Mar
4406.00
(0.58%)

25 Mar
4380.55
(0.69%)

24 Mar
4350.50
(-0.50%)

23 Mar
4372.25
(0.42%)

22 Mar
4353.95
(1.86%)

19 Mar
4274.45
(1.46%)

18 Mar
4212.75
(-3.29%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Neutral

Moving Averages

5 DMA

Bullish

4928.11

10 DMA

Bullish

4838.73

20 DMA

Bullish

4635.26

50 DMA

Bullish

4591.4

100 DMA

Bullish

4819.25

200 DMA

Bullish

4724.17

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 20, 2021 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	5336.41	5273.58	5190.09	-	-
R2	5273.58	5227.26	5178.98	5274.69	-
R1	5215.16	5198.65	5167.86	5217.38	5244.38
P	5152.33	5152.33	5152.33	5153.44	5166.94
S1	5093.91	5106.01	5145.64	5096.13	5123.13
S2	5031.08	5077.4	5134.52	5032.19	-
S3	4972.66	5031.08	5123.41	-	-

Key Metrics

EPS

142.98

P/E

36.05

P/B

5.26

Dividend Yield

0.48%

Market Cap

85,757 Cr.

Face Value

5

Book Value

979.36

ROE

13.68%

EBITDA Growth

623.9 Cr.

Debt/Equity

0.2

Shareholding Pattern

	26.74%	Total Promoter Holding

	13.31%	Mutual Fund Holdings

	29.03%	FIIs

	28.99%	Non Institution

	0.86%	Insurance Companies

	0.35%	Custodians

	0.72%	Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Quaterly Results

	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020
INCOME	4482	4533	4521.3	4969.4	5027.5
PROFIT	-538.4	781.1	594.6	771.8	27.9
EPS	-32.48	47.12	35.87	46.54	1.68

Dr Reddys Laboratories Ltd Quaterly Results

	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020
INCOME	3113.3	2979.1	3889.1	3372.4	3471
PROFIT	521.7	502.8	950.2	481	443.7
EPS	31.47	30.24	57.31	29	26.74

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
INCOME	7652	10099.4	12151	13904.6	15353.2	15959	14490.9	14477.7	16104.9	18170
PROFIT	979.35	1392.03	1514.4	1945.62	2291.79	2071.62	1252.3	892.34	1849.63	2030.35
EPS	57.21	74.48	87.37	112.29	133.04	123.55	75.83	54.96	117.47	121.9

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
INCOME	5441.4	6926.3	8612.7	10050.1	10262.7	10645.6	10309.1	9614.9	10797.9	12693.5
PROFIT	893.56	903.32	1251.28	1926.89	1634.01	1320.26	1406.23	536.19	1274.22	2948.85
EPS	50.98	51.57	71.98	113.56	94.48	80.56	83.48	34.15	76.95	176.76

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
SOURCES OF FUNDS :
Share Capital	83.1	83	83	82.9	85.3	85.2	85.1	84.9	84.8	84.6
Reserves Total	15,616.3	13,994.1	12,488.6	12,179.2	12,484.5	9,767.9	7,780.1	6,284.2	4,904.2	3,947.3
Equity Application Money	-100.6	-53.5	0	0	0	0	0	0	0	0
Total Shareholders Funds	15,598.8	14,023.6	12,571.6	12,262.1	12,569.8	9,853.1	7,865.2	6,369.1	4,989	4,031.9
Secured Loans	178.7	60.9	69.3	70.7	85.7	86.2	104.7	88.2	33.8	28.3
Unsecured Loans	2,031.5	3,777.2	5,002.1	4,847.8	3,266.4	4,227.9	4,372.3	3,594	3,200.1	2,342.4
Total Debt	2,210.2	3,838.1	5,071.4	4,918.5	3,352.1	4,314.1	4,477	3,682.2	3,233.9	2,370.7
Other Liabilities	280	297.4	375	427.6	344.5	351.2	174.4	86.4	82.8	85.6
Total Liabilities	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7	8,305.7	6,488.2
APPLICATION OF FUNDS :
Gross Block	16,108.2	14,998.6	17,436.3	15,932.4	15,019.7	12,573.6	11,917.6	10,089.4	8,842.3	7,975.1
Less: Accumulated Depreciation	9,257.9	7,807.6	10,468.3	9,001.7	8,456.7	7,196.6	7,276.8	6,038.8	5,430.6	4,589.6
Net Block	6,850.3	7,191	6,968	6,930.7	6,563	5,377	4,640.8	4,050.6	3,411.7	3,385.5
Capital Work in Progress	1,535.1	2,933.5	3,470.5	3,324.5	772.2	529	638.8	565.3	708.5	575.2
Investments	2,677.8	2,587.1	2,298.3	2,109.7	3,833.1	2,247.8	1,066.8	197	207.9	0.9
Inventories	3,506.7	3,357.9	2,908.9	2,852.8	2,557.9	2,569.9	2,418.8	2,170.7	1,943.3	1,599.2
Sundry Debtors	5,027.8	3,986.9	4,052.7	3,798.6	4,125	4,101.2	3,325.3	3,180.4	2,536.8	1,761.1
Cash and Bank Balance	205.3	222.8	263.8	386.5	492.1	1,872.4	2,300.6	2,017.1	1,606.1	575.1
Loans and Advances	1,490.6	1,289.6	1,440	1,218.7	1,115.6	1,231	1,214.6	961.9	705.8	879.6
Total Current Assets	10,230.4	8,857.2	8,665.4	8,256.6	8,290.6	9,774.5	9,259.3	8,330.1	6,792	4,815
Current Liabilities	4,610.2	3,762.2	3,739.6	3,385.6	3,304.6	2,794.8	2,573.2	2,568.4	2,502.6	1,961.8
Provisions	524.1	497	591.7	660.7	759.4	1,143.9	815.7	674.1	496.8	413.2
Total Current Liabilities & Provisions	5,134.3	4,259.2	4,331.3	4,046.3	4,064	3,938.7	3,388.9	3,242.5	2,999.4	2,375
Net Current Assets	5,096.1	4,598	4,334.1	4,210.3	4,226.6	5,835.8	5,870.4	5,087.6	3,792.6	2,440
Deferred Tax Assets	1,219.9	431.7	540.5	678.4	590.5	260.5	191.7	174.2	245.7	147.8
Deferred Tax Liability	2	47.3	195	162	53.7	156.2	124.1	107	130.8	125.3
Net Deferred Tax	1,217.9	384.4	345.5	516.4	536.8	104.3	67.6	67.2	114.9	22.5
Other Assets	711.8	465.1	601.6	516.6	334.7	424.5	232.2	170	70.1	64.1
Total Assets	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7	8,305.7	6,488.2
Contingent Liabilities	117.6	138	277.57	102.17	92.17	190	221.6	112.6	178.7	139.3

	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
SOURCES OF FUNDS :
Share Capital	83.1	83	83	82.9	85.3	85.2	85.1	84.9	84.8	84.6
Reserves Total	15,209.4	12,654.6	11,724.8	11,517.7	11,993.1	10,548.8	9,243.9	7,698.5	6,633	5,935.6
Equity Application Money	-100.6	-53.5	0	0	0	0	0	0	0	0
Total Shareholders Funds	15,191.9	12,684.1	11,807.8	11,600.6	12,078.4	10,634	9,329	7,783.4	6,717.8	6,020.2
Secured Loans	19.3	0	0	0	0.9	1.4	1.7	4.7	2.3	0.3
Unsecured Loans	1,437.6	1,064.6	2,588.8	2,355.2	3,084.2	3,124.7	2,664.5	2,095.3	1,533.1	1,535.6
Total Debt	1,456.9	1,064.6	2,588.8	2,355.2	3,085.1	3,126.1	2,666.2	2,100	1,535.4	1,535.9
Other Liabilities	84.1	83.2	84.6	103.4	123.6	75.3	38.2	32.6	27.5	25.7
Total Liabilities	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916	8,280.7	7,581.8
APPLICATION OF FUNDS :
Gross Block	10,215.9	9,774.1	9,223.6	8,675.4	7,580	5,815.6	4,899.7	4,208.7	3,507.8	3,025
Less : Accumulated Depreciation	5,782	5,091.4	4,506.3	3,833.3	3,141.9	2,566.2	2,151.4	1,821.7	1,611	1,334
Net Block	4,433.9	4,682.7	4,717.3	4,842.1	4,438.1	3,249.4	2,748.3	2,387	1,896.8	1,691
Capital Work in Progress	411.8	400.1	675	540	616.1	488.3	576.1	423.2	617.6	546
Investments	5,485.5	3,933.5	3,636.5	3,101.9	5,076.1	3,862.3	2,806.5	2,379.2	2,477.7	2,462
Inventories	2,190.4	2,015.6	1,856.8	1,809.7	1,699.6	1,723.3	1,592.1	1,526.5	1,326.7	1,063.2
Sundry Debtors	4,638.7	3,717.7	4,203.8	4,405.4	3,889.5	4,711.7	4,561.5	2,963.9	1,943.5	1,770.5
Cash and Bank Balance	39.2	113.2	120.7	66.8	202.1	901.4	665.1	919.1	849	66.2
Loans and Advances	1,120	972.3	1,174.4	1,012.8	1,121.9	964.7	1,022.7	994.1	597.5	752.8
Total Current Assets	7,988.3	6,818.8	7,355.7	7,294.7	6,913.1	8,301.1	7,841.4	6,403.6	4,716.7	3,652.7
Current Liabilities	2,535.6	2,175.4	2,445.7	2,179.6	2,127.5	1,952.1	1,870	1,558	1,715.8	1,304
Provisions	207.3	184.7	173.4	208.4	170.6	539.5	479.5	421.4	324.1	276.8
Total Current Liabilities & Provisions	2,742.9	2,360.1	2,619.1	2,388	2,298.1	2,491.6	2,349.5	1,979.4	2,039.9	1,580.8
Net Current Assets	5,245.4	4,458.7	4,736.6	4,906.7	4,615	5,809.5	5,491.9	4,424.2	2,676.8	2,071.9
Deferred Tax Assets	867.3	214.1	346.5	382.8	306	35.7	23.1	32.5	82.1	23.7
Deferred Tax Liability	254.4	269.6	253.4	300.7	242.5	164.7	148.3	126.2	102.1	124.5
Net Deferred Tax	612.9	-55.5	93.1	82.1	63.5	-129	-125.2	-93.7	-20	-100.8
Other Assets	543.4	412.4	622.7	586.4	478.3	554.9	535.8	396.1	631.8	911.7
Total Assets	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916	8,280.7	7,581.8
Contingent Liabilities	117.6	316.2	305.37	102.17	92.17	1,231.9	1,605.2	1,740	1,867.2	1,246.3

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 2,984.1

Net Profit before Tax and Extr...	1,885.7
Depreciation	1,163.1
Interest (Net)	9.5
Dividend Received	39.2
P/L on Sales of Assets	6.8
Prov. and W/O (Net)	1,695.7
P/L in Forex	-215.2
Others	-47.4
Total Adjustments (PBT and Ext...	2,562.5
Operating Profit before Workin...	4,448.2
Trade and 0ther Receivables	-1,244.6
Inventories	-148.7
Trade Payables	157.6
Total Adjustments (OP before W...	-753.6
Cash Generated from/(used in) ...	3,694.6
Direct Taxes Paid	-710.5
Total Adjustments(Cash Generat...	-710.5
Cash Flow before Extraordinary...	2,984.1
Net Cash from Operating Activi...	2,984.1

Cash from Investing Activity -494.8

Purchased of Fixed Assets	-611.5
Sale of Fixed Assets	39
Purchase of Investments	-11,191.8
Sale of Investments	11,170.4
Interest Received	62.4
Net Cash used in Investing Act...	-494.8

Cash from Financing Activity -2,515.9

Proceeds from Issue of shares ...	0.4
Proceed from Short Tem Borrowi...	423.5
Of the Long Tem Borrowings	-2,291.8
Of Financial Liabilities	-48.2
Dividend Paid	-391.6
Interest Paid	-160.8
Net Cash used in Financing Act...	-2,515.9

Cash from Operating Activity 1,839.2

Net Profit before Tax and Extr...	2,775.8
Depreciation	789.2
Interest (Net)	-37.8
Dividend Received	39.7
P/L on Sales of Assets	13.5
Prov. and W/O (Net)	9.5
P/L in Forex	-22.9
Others	-47.4
Total Adjustments (PBT and Ext...	681.8
Operating Profit before Workin...	3,457.6
Trade and 0ther Receivables	-1,092.7
Inventories	-174.8
Trade Payables	36.8
Total Adjustments (OP before W...	-1,141.5
Cash Generated from/(used in) ...	2,316.1
Direct Taxes Paid	-476.9
Total Adjustments(Cash Generat...	-476.9
Cash Flow before Extraordinary...	1,839.2
Net Cash from Operating Activi...	1,839.2

Cash from Investing Activity -1,689.2

Purchased of Fixed Assets	-473.8
Sale of Fixed Assets	5.8
Purchase of Investments	-12,272.6
Sale of Investments	10,918.6
Interest Received	58.8
Net Cash used in Investing Act...	-1,689.2

Cash from Financing Activity -224.1

Proceeds from Issue of shares ...	0.4
Proceed from Short Tem Borrowi...	463
Of the Long Tem Borrowings	-180.5
Of Financial Liabilities	-15.5
Dividend Paid	-391.4
Interest Paid	-52.7
Net Cash used in Financing Act...	-224.1

News

Company Details

Registered Office
Address	8-2-337 Road No 3, Banjara Hills
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Registrars
Address	8-2-337 Road No 3
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Management
Name	Designation
G V Prasad	Co-Chairman & Managing Directo
K Satish Reddy	Chairman
Kalpana Morparia	Independent Director
Sandeep Poddar	Company Secretary
Bruce L A Carter	Independent Director
Sridar Iyengar	Independent Director
Bharat N Doshi	Independent Director
Prasad R Menon	Independent Director
Shikha Sanjaya Sharma	Independent Director
Allan Oberman	Independent Director
Leo Puri	Independent Director

EquityPandit

Copyright © 2014 EquityPandit Financial Services Pvt. Ltd.
All rights reserved.

SEBI Registered Investment Advisor
SEBI Registration Number : INA000006688
An ISO 9001:2008 Certified Company
Investment/Trading in markets is subject to market risk.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.